[ad_1]
RIO – The National Sanitary Surveillance Agency (Anvisa) reported that it received a complaint for the sale of a fake vaccine against Covid-19 in Niterói, Rio de Janeiro. According to the regulator, a company is selling the counterfeit immunizer and claims it is a vaccine in development by the University of Oxford and AstraZeneca.
WHO:Herd immunity “just isn’t ethical”
“Anvisa received the complaint about the alleged irregular marketing of the vaccine against Covid-19 through its official channels, indicating that the Oxford vaccine against Covid-19 was being made available by a company located in Niterói / RJ,” said Anvisa .
“The complaint was filed on September 25 and that same day an assessment and formal referral was made to the General Directorate of the Federal Police.”
The agency reiterates that there is still no vaccine against Covid-19 authorized for commercialization in Brazil. Until its launch, Anvisa requests that supposed immunizations against the disease are not acquired.
COVID-19: Against the WHO, group of scientists calls for quarantine only for the elderly
“There are vaccines against Covid-19 in Brazil, exclusively for use in clinical studies. There is no permission for the marketing and distribution of these vaccines,” said the Anvisa note.
Vaccine in tests
Still in the testing phase and without approval for sale in Brazil, the vaccine developed by AstraZeneca, in association with the University of Oxford, is considered by the Brazilian government as one of the main bets for immunization against Covid-19. For now, only the volunteers are receiving a dose of the immunizer and in a controlled manner by the responsible institutions.
Read More: Amid the pandemic, cariocas enjoy vacations on the edge of Rio
The Health Ministry says it is monitoring more than 200 studies against the disease in the country. “No effort will be spared to make available to Brazilians, as soon as possible, an effective vaccine, in quantity and quality, to serve the population,” says the folder, in a note.
